Kazuyoshi Ikuta

HIV incomplete particles and a method for production thereof.

Monoclonal antibody against human CD4 peptide

Anti-hiv peptide or peptide derivative

H.I.V. treatment utilizing specific inhibitation of protein syntheses in a cell

Liposomes cytotoxic to virus-infected cells

Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear @@S ' cells.

CD4-fragment having anti-HIV activity.

Treatment of viral infection

E Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein

Stimulation of human immunodeficiency virus type 1 infected cells with superoxide enhances the chemotactic motile response of CD4+ human cells: implication for virus transmission by cell-to-cell interaction.